NEW YORK (GenomeWeb News) – Luminex today said that the US Food and Drug Administration has cleared labeling updates for its xTAG Respiratory Viral Panel to include data about the performance of the test in humans infected with the pandemic A/H1N1 influenza virus, also known as swine flu.

The labeling will now include information from two studies that Luminex said shows that xTAG RVP can be an effective aid in detecting the virus, but cannot identify the hemagglutinin gene of the 2009 influenza A/H1N1 in clinical specimens.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.